Biktarvy Alternatives Compared
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Descovy (emtricitabine / tenofovir alafenamide) | Bictegravir / emtricitabine / tenofovir alafenamide |
|
|---|
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Descovy (emtricitabine / tenofovir alafenamide) | Bictegravir / emtricitabine / tenofovir alafenamide |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection. Descovy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | More about Descovy (emtricitabine / tenofovir alafenamide) | More about Bictegravir / emtricitabine / tenofovir alafenamide | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Biktarvy has an average rating of 7.2 out of 10 from a total of 214 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 19% reported a negative effect. |
Descovy has an average rating of 6.9 out of 10 from a total of 19 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.2 out of 10 from a total of 216 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
Bictegravir / emtricitabine / tenofovir alafenamide side effects |
||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Biktarvy prices |
View all Descovy prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Biktarvy | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
180 hours |
25.7 hours |
180 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 433 drugs are known to interact with Biktarvy:
|
A total of 240 drugs are known to interact with Descovy:
|
A total of 433 drugs are known to interact with Bictegravir / emtricitabine / tenofovir alafenamide:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
February 07, 2018 |
April 04, 2016 |
February 07, 2018 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.